Concepedia

Sudhakar Ammanamanchi

SA

Statistics

Publications

16

Citations

817

H-Index

15

Active since

1998

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

University of Toledo Medical Center

Roswell Park Comprehensive Cancer Center

Murphy Oil Corporation (United States)

Sudhakar Ammanamanchi is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, cancer cell signaling, and transcriptional regulation.

ORCID

Publications per year

1998–2022

16

Publications

16

Acetylated Sp3 Is a Transcriptional Activator

Sudhakar Ammanamanchi, James W. Freeman, Michael G. Brattain · Journal of Biological Chemistry · 2003 · 127 citations · Full text

, , +14

Trichostatin A Induces Transforming Growth Factor β Type II Receptor Promoter Activity and Acetylation of Sp1 by Recruitment of PCAF/p300 to a Sp1·NF-Y Complex

Weiqi Huang, Shujie Zhao, Sudhakar Ammanamanchi et al. · Journal of Biological Chemistry · 2005 · 118 citations · Full text

, , +16

Restoration of Transforming Growth Factor-β Signaling through Receptor RI Induction by Histone Deacetylase Activity Inhibition in Breast Cancer Cells

Sudhakar Ammanamanchi, Michael G. Brattain · Journal of Biological Chemistry · 2004 · 72 citations · Full text

, , +17

Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.

JianGen Gong, Sudhakar Ammanamanchi, Tien C. Ko et al. · PubMed · 2003 · 68 citations

, , +17

Induction of Transforming Growth Factor-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cells through SP1 Activation by 5-Aza-2′-deoxycytidine

Sudhakar Ammanamanchi, Seong‐Jin Kim, Lu‐Zhe Sun et al. · Journal of Biological Chemistry · 1998 · 65 citations · Full text

, , +17

1–5 of 16